Evidence map›Paper›PMID 32456959›Full record

ArticleThe Journal of emergency medicine2020

The Ocular Manifestations and Transmission of COVID-19: Recommendations for Prevention.

Dominique M Dockery, Susannah G Rowe, Marjorie A Murphy, Magdalena G Krzystolik

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of emergency medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Ocular symptoms in COVID-19 infection: a survey study.Journal of ophthalmic inflammation and infection · 2022
    Article
  11. Eye-Related COVID-19: A Bibliometric Analysis of the Scientific Production Indexed in Scopus.International journal of environmental research and public health · 2022
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Adverse Ocular Events following COVID-19 Vaccination.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Dominique M DockeryDepartment of Ophthalmology, Warren Alpert Medical School of Brown University, Providence, Rhode Island.
Susannah G RoweDepartment of Ophthalmology, Boston University School of Medicine, Boston, Massachusetts.
Marjorie A MurphyDepartment of Ophthalmology, Warren Alpert Medical School of Brown University, Providence, Rhode Island.
Magdalena G KrzystolikDepartment of Ophthalmology, Warren Alpert Medical School of Brown University, Providence, Rhode Island.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCoronavirus disease-2019 (COVID-19), caused by a novel coronavirus termed severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has been linked to ocular signs and symptoms in several case reports. Research has demonstrated that SARS-CoV-2 is spread primarily through close contact via respiratory droplets, but there is the possibility for ocular transmission, with the conjunctiva as a conduit as well as a source of infection. DISCUSSION: Ocular manifestations of SARS-CoV-2 include follicular conjunctivitis, and have been repeatedly noted as an initial or subsequent symptom of COVID-19-positive patients. Particularly in patients with ocular manifestations, there is evidence that the virus may present in tears, based on the detection of SARS-CoV-2 in conjunctival swab samples via reverse transcription polymerase chain reaction. The virus may therefore be transmittable from the ocular surface to a new host via contact with the ocular mucosa, tears, or subsequent fomites.

conclusionsAll health care professionals should ask patients about ocular symptoms consistent with SARS-CoV-2, and use eye protection such as goggles or face shields as part of the standard personal protective equipment for high-risk patients in addition to wearing of masks by both the patient and provider, and should consider tears to be potentially infectious.

Indexed as

CoronavirusCoronavirus InfectionsPandemicsBetacoronavirusCOVID-19HumansPneumonia, ViralSARS-CoV-2TropismconjunctivitisCOVID-19ocular transmissionophthalmic precautionsSARS-CoV-2

Identifiers

PMID32456959
PMCPMC7205711

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.